Vimarsana
Biggest News Aggregation in the World

Transparency On Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transparency On Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transparency On Trial Today - Breaking & Trending Today

Women in Science: Dr Laura Trotta – 'I joined CluePoints because of the research but also the mindset' - Vimarsana News

Women in Science: Dr Laura Trotta – 'I joined CluePoints because of the research but also the mindset'

Dr Laura Trotta joined CluePoints in 2015 and moved into her current role as vice president of research in January 2022, where she leads a team of research scientists responsible for developing new statistical and machine learning algorithms to assess the quality of clinical trial data.

Interview: Gen Li, president and founder of Phesi on data management - Vimarsana News

Interview: Gen Li, president and founder of Phesi on data management

Gen Li is president and founder of Phesi. Equally, OSP was delighted to speak to him to discuss the evolution of data management in clinical development and how intelligent data use can reduce clinical trial cancellations, minimise protocol amendments, and accelerate patient recruitment.

Five decentralized clinical trial organizations raising big VC cash - Vimarsana News

Five decentralized clinical trial organizations raising big VC cash

Decentralized clinical trials (DCTs) are gaining increasing interest as they have the potential to make clinical trial operations quicker, more efficient and more accessible to patients. Check out five DCT organizations that have raised big venture capital investments in the last few years.

The key pharmaceutical trends from 2023 according to industry leaders - Vimarsana News

The key pharmaceutical trends from 2023 according to industry leaders

The pharmaceutical industry in 2023 has seen many investments, partnerships, acquisitions and more. As the year ends, industry leaders give the biggest trends to look for in 2024, with artificial intelligence being a hot topic.

FDA approval expands Welireg to patients with renal cell carcinoma - Vimarsana News

FDA approval expands Welireg to patients with renal cell carcinoma

The oral treatment belzutifan, developed by MSD (known as Merck in the US) and branded as Welireg, has received the green light from the US Food and Drug Administration (FDA) for the treatment of an advanced form of renal cell carcinoma (RCC).